Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Cyclo Therapeutics

Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
From Cyclo Therapeutics
Via Business Wire
Tickers CYTH
Cyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results
From Cyclo Therapeutics
Via Business Wire
Tickers CYTH
Cyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements
From Cyclo Therapeutics
Via Business Wire
Tickers CYTH
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.